1. An Investigation of Proportion Designs Based on a Molecularly Targeted Endpoint

   • Seung-Ho Kong
   • Sangmee Lee
   • Chul W. Ahn

   Clinical Trials 31 December 2008 Pages: 527 - 535

2. The Importance of Medical Innovation in an Investigator’s Decision to Take Part in Clinical Trials

   • Harold E. Gloss

   Clinical Trials 31 December 2008 Pages: 537 - 543

3. Confirm and Explore: A Stepwise Approach to Clinical Study Designs

   • Naitee Ting

   Clinical Trials 31 December 2008 Pages: 545 - 554

4. Publishing a Drug Information Bulletin: Experiences From a Developing Country

   • P. Ravi Shankar
   • P. Subish
   • Pranaya Mishra

   Drug Information 31 December 2008 Pages: 555 - 559

5. Opening the Black Box of Pharmaceutical Patent Value: An Empirical Analysis

   • Yuanjia Hu
   • Ying Bian
   • Yitao Wang

   Drug Information 31 December 2008 Pages: 561 - 568

6. Legal Requirements for Drug Information Resources Maintained by Pharmacies

   • Kevin A. Clauson
   • Jennifer A. Fass
   • Matthew J. Seamon

   Drug Information 31 December 2008 Pages: 569 - 582

7. A Comparative Study of the Communication of Drug Safety Information by Governmental Agencies in Japan and Western Countries: The Case of Asthma Medications

   • Michiko Yamamoto
   • Takeo Nakayama

   Drug Information 31 December 2008 Pages: 583 - 596

8. Accounting for Interim Analyses in the Assessment of Program Expected Net Present Value

   • Lee Kaiser
   • Jeffrey Helterbrand
   • Hal Barron

   Statistics 31 December 2008 Pages: 597 - 606

9. A Noninferiority Margin for Acne Lesion Counts

   • Christoph Gerlinger
   • Gerald Städtler
   • Jan Endrikat

   Statistics 31 December 2008 Pages: 607 - 615

10. Statistical Test for Ordered Categorical Data in Clinical Trials

    • Shein-Chung Chow
    • Siu-Keung Tse
    • Eric Chi

    Statistics 31 December 2008 Pages: 617 - 624

11. How Biased Are Indirect Comparisons, Particularly When Comparisons Are Made Over Time in Controlled Trials?

    • Steven A. Julious
    • Sue-Jane Wang

    Statistics 31 December 2008 Pages: 625 - 633

12. A Review of Pharmacoepidemiology and Therapeutic Risk Management

    • Steven F. Hoff

    Book Review 31 December 2008 Pages: 635 - 636